drugset / Trial / NCT04408092
Study of the Effect of GM-CSF on Macrophages in Ependymoma
Phase 0
Completed
6 enrolled
University of Colorado, Denver
Children's Hospital Colorado · collabNational Cancer Institute (NCI) · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study plans to learn more about the use of Granulocyte Macrophage Colony Stimulation Factor (GM-CSF) on ependymoma tumors. The use of GM-CSF is a potential way of increasing the infiltration of immune cells and this study is looking at whether or not this will improve the outcome of patients with an ependymoma
Timeline
- Start
- 2013-06-25
- Primary completion
- 2021-09-21
- Completion
- 2023-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sargramostim | Protein / enzyme biologic | — | — |